Effect of 1.25(OH)₂D₃ treatment on proteinuria at different time points after the induction of glomerulonephritis. حسب Jian-feng Li (8667645)

الموضوعات:

IL-33 supplementation fails to prevent trTreg reduction in established <i>T</i>. <i>cruzi</i> infection. حسب Santiago Boccardo (5927954)

الموضوعات:

Changes in alpha diversity in the weeks before anti-TNF-a treatment. حسب Katrine Carlsen (5477300)

الموضوعات:

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. حسب Jelena Filimonovic (22305307)

Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients. حسب Ningning Wang (560944)

الموضوعات:

The cleft width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات:

The number, age, and weight of the patients with cleft lip and palate in the velar adhesion VA group and non-VA group. حسب Miki Kashiwagi (21439684)

الموضوعات:

Measurement of the patients’ dental cast models. حسب Miki Kashiwagi (21439684)

الموضوعات:

The dental arch length at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات:

The alveolar width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات:

Velar adhesion (VA). حسب Miki Kashiwagi (21439684)

الموضوعات:

(A) The incidence of OME in the VA group compared to the non-VA group. (B) The rate of tympanostomy tube insertion in the VA group and non-VA group. حسب Miki Kashiwagi (21439684)

الموضوعات:

The dental arch width at three timepoints: (A) at the patient’s birth, (B) at cheiloplasty, and (C) at palatoplasty. حسب Miki Kashiwagi (21439684)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Flowchart of patient selection in this study. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

S1 Data - حسب Kazuyoshi Ohkawa (836847)

الموضوعات:

Clinical course of patient no. حسب Kazuyoshi Ohkawa (836847)

الموضوعات: